These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25360682)

  • 21. Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.
    Weng PH; Huang YL; Page JH; Chen JH; Xu J; Koutros S; Berndt S; Chanock S; Yeager M; Witte JS; Eeles RA; Easton DF; Neal DE; Donovan J; Hamdy FC; Muir KR; Giles G; Severi G; Smith JR; Balistreri CR; Shui IM; Chen YC
    PLoS One; 2014; 9(10):e110569. PubMed ID: 25360682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
    Kutikhin AG
    Hum Immunol; 2011 Feb; 72(2):193-206. PubMed ID: 21081146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between TLR4 Polymorphisms and Open Angle Glaucoma: A Meta-Analysis.
    Lin Z; Huang S; Sun J; Xie B; Zhong Y
    Biomed Res Int; 2019; 2019():6707650. PubMed ID: 31428642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study.
    Huang WH; Nie LH; Zhang LJ; Jing LP; Dong F; Wang M; Zhang N; Liu Y; Zhang BH; Chen C; Lin HS; Wei XC; Yang G; Jing CX
    Genet Mol Res; 2015 Jul; 14(3):8694-705. PubMed ID: 26345801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.
    Balistreri CR; Candore G; Lio D; Carruba G
    Cancer Gene Ther; 2014 Jan; 21(1):2-11. PubMed ID: 24407349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis.
    Zhu L; Yuan H; Jiang T; Wang R; Ma H; Zhang S
    PLoS One; 2013; 8(12):e82858. PubMed ID: 24376595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer statistics, 2013.
    Siegel R; Naishadham D; Jemal A
    CA Cancer J Clin; 2013 Jan; 63(1):11-30. PubMed ID: 23335087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis.
    Zhang K; Zhou B; Wang Y; Rao L; Zhang L
    Eur J Cancer; 2013 Mar; 49(4):946-54. PubMed ID: 23084080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technical reproducibility of genotyping SNP arrays used in genome-wide association studies.
    Hong H; Xu L; Liu J; Jones WD; Su Z; Ning B; Perkins R; Ge W; Miclaus K; Zhang L; Park K; Green B; Han T; Fang H; Lambert CG; Vega SC; Lin SM; Jafari N; Czika W; Wolfinger RD; Goodsaid F; Tong W; Shi L
    PLoS One; 2012; 7(9):e44483. PubMed ID: 22970228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
    Jing JJ; Li M; Yuan Y
    Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
    Nam RK; Zhang W; Siminovitch K; Shlien A; Kattan MW; Klotz LH; Trachtenberg J; Lu Y; Zhang J; Yu C; Toi A; Loblaw DA; Venkateswaran V; Stanimirovic A; Sugar L; Malkin D; Seth A; Narod SA
    Cancer Biol Ther; 2011 Dec; 12(11):997-1004. PubMed ID: 22130093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide association study identifies new prostate cancer susceptibility loci.
    Schumacher FR; Berndt SI; Siddiq A; Jacobs KB; Wang Z; Lindstrom S; Stevens VL; Chen C; Mondul AM; Travis RC; Stram DO; Eeles RA; Easton DF; Giles G; Hopper JL; Neal DE; Hamdy FC; Donovan JL; Muir K; Al Olama AA; Kote-Jarai Z; Guy M; Severi G; Grönberg H; Isaacs WB; Karlsson R; Wiklund F; Xu J; Allen NE; Andriole GL; Barricarte A; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gonzalez CA; Gaziano JM; Giovannucci EL; Johansson M; Le Marchand L; Ma J; Sieri S; Stattin P; Stampfer MJ; Tjonneland A; Vineis P; Virtamo J; Vogel U; Weinstein SJ; Yeager M; Thun MJ; Kolonel LN; Henderson BE; Albanes D; Hayes RB; Feigelson HS; Riboli E; Hunter DJ; Chanock SJ; Haiman CA; Kraft P
    Hum Mol Genet; 2011 Oct; 20(19):3867-75. PubMed ID: 21743057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
    Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
    Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
    FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.
    Balistreri CR; Caruso C; Carruba G; Miceli V; Campisi I; Listì F; Lio D; Colonna-Romano G; Candore G
    Curr Pharm Des; 2010; 16(6):718-24. PubMed ID: 20388081
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.